Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intravitreal Injection Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00973011
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Genentech, Inc. 18
Not applicableStudy completedNCT07717944
What this trial is testing

Phacovitrectomy Versus Pars Plana Vitrectomy Alone for Post-Intravitreal Injection Endophthalmitis

Who this might be right for
EndophthalmitisEndophthalmitis PostoperativeIntravitreal Injection Patients
Benha University 40
Not applicableStudy completedNCT04340505
What this trial is testing

Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant

Who this might be right for
Uveitis
The Cleveland Clinic 30
Post-approval studies (Phase 4)Study completedNCT03211741
What this trial is testing

Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema

Who this might be right for
Retinal NeovascularizationMacular Edema
University Hospital, Ghent 583
Early research (Phase 1)Study completedNCT00536016
What this trial is testing

Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD

Who this might be right for
Macular Degeneration
Jerini Ophthalmic 36
Post-approval studies (Phase 4)Study completedNCT02257632
What this trial is testing

Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis Pharmaceuticals 41
Large-scale testing (Phase 3)Study completedNCT03495765
What this trial is testing

To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus

Who this might be right for
Diabetic Macular Oedema
Marsden Eye Specialists 160
Large-scale testing (Phase 3)Study completedNCT01363440
What this trial is testing

Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Regeneron Pharmaceuticals 466
Large-scale testing (Phase 3)Study completedNCT00321997
What this trial is testing

A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 540
Early research (Phase 1)Ended earlyNCT01086761
What this trial is testing

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Allergan 32
Testing effectiveness (Phase 2)Study completedNCT00373659
What this trial is testing

An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
University of Miami 40
Large-scale testing (Phase 3)Study completedNCT01521559
What this trial is testing

Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein Occlusion
Regeneron Pharmaceuticals 183
Testing effectiveness (Phase 2)Study completedNCT05275205
What this trial is testing

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

Who this might be right for
Neovascular Age-related Macular Degeneration
Unity Biotechnology, Inc. 51
Not applicableStudy completedNCT03290794
What this trial is testing

Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 100
Not applicableStudy completedNCT01087489
What this trial is testing

Comparison of Patient Comfort After Two Anesthetic Protocols for Injections Into the Eye

Who this might be right for
Pain
Miami VA Healthcare System 53
Very early researchNot Yet RecruitingNCT06888492
What this trial is testing

To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 8
Large-scale testing (Phase 3)Study completedNCT04278417
What this trial is testing

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Novartis Pharmaceuticals 689
Testing effectiveness (Phase 2)Ended earlyNCT04607148
What this trial is testing

A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration, Age-RelatedGeographic Atrophy
Genentech, Inc. 144
Early research (Phase 1)WithdrawnNCT04830878
What this trial is testing

Methotrexate For The Prevention and Treatment of Proliferative Vitreoretinopathy in Pediatric Patients

Who this might be right for
Proliferative Vitreoretinopathy
Stanford University
Not applicableNot Yet RecruitingNCT07821450
What this trial is testing

Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study

Who this might be right for
BlepharoptosisAge-Related Macular DegenerationDiabetic Macular Edema
Abdulkadir Küçük 60
Next Page